Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993001839> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W1993001839 endingPage "356" @default.
- W1993001839 startingPage "351" @default.
- W1993001839 abstract "The best management of patients with low-stage, high-grade prostate cancer remains unclear. In an attempt to improve the outcomes of this high-risk group, we have offered those with Gleason > or =7 cancers removable-source high-dose-rate (HDR) brachytherapy in combination with external-beam radiation.We reviewed the clinical histories of 61 consecutive patients with high-grade clinical stage T1-T2 lesions who received the combination radiation therapy between March 1997 and November 1998. The average Gleason score was 7.5. The HDR brachytherapy was given in three sessions with removable-source afterloaded (192)Ir to a minimum peripheral dose of 6 Gy. Conformal external-beam radiation in 25 fractions to a dose of 50 Gy was given beginning 1 week later. Patients with prostate volumes >40 cc received a luteinizing hormone-releasing hormone analog before brachytherapy.Among the 52 patients available for follow-up (average duration 11.8 months), there has been one death from prostate cancer. After treatment, only one patient had an initial rise in serum prostate specific antigen (PSA) concentration. In addition to the patient who died, there have been three confirmed treatment failures. Toxicity was mild, with only two patients having RTOG grade 3 or 4 effects. Neither of them required surgery.Although long-term results are not available, available data suggest that HDR brachytherapy plus external-beam radiation is at least as effective as any single therapy for high-risk, low-stage prostate cancer. The toxicity is acceptable." @default.
- W1993001839 created "2016-06-24" @default.
- W1993001839 creator A5013286312 @default.
- W1993001839 creator A5028376473 @default.
- W1993001839 creator A5056283799 @default.
- W1993001839 creator A5065763923 @default.
- W1993001839 creator A5074921549 @default.
- W1993001839 date "2000-05-01" @default.
- W1993001839 modified "2023-09-27" @default.
- W1993001839 title "Treatment of High-Grade Low-Stage Prostate Cancer by High-Dose-Rate Brachytherapy" @default.
- W1993001839 cites W2049153532 @default.
- W1993001839 cites W2051236771 @default.
- W1993001839 cites W2071879495 @default.
- W1993001839 cites W2089526714 @default.
- W1993001839 cites W2509770496 @default.
- W1993001839 cites W31616992 @default.
- W1993001839 cites W4252605154 @default.
- W1993001839 cites W4293658047 @default.
- W1993001839 doi "https://doi.org/10.1089/end.2000.14.351" @default.
- W1993001839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10910151" @default.
- W1993001839 hasPublicationYear "2000" @default.
- W1993001839 type Work @default.
- W1993001839 sameAs 1993001839 @default.
- W1993001839 citedByCount "12" @default.
- W1993001839 countsByYear W19930018392012 @default.
- W1993001839 countsByYear W19930018392014 @default.
- W1993001839 countsByYear W19930018392017 @default.
- W1993001839 crossrefType "journal-article" @default.
- W1993001839 hasAuthorship W1993001839A5013286312 @default.
- W1993001839 hasAuthorship W1993001839A5028376473 @default.
- W1993001839 hasAuthorship W1993001839A5056283799 @default.
- W1993001839 hasAuthorship W1993001839A5065763923 @default.
- W1993001839 hasAuthorship W1993001839A5074921549 @default.
- W1993001839 hasConcept C121608353 @default.
- W1993001839 hasConcept C126322002 @default.
- W1993001839 hasConcept C126838900 @default.
- W1993001839 hasConcept C126894567 @default.
- W1993001839 hasConcept C146357865 @default.
- W1993001839 hasConcept C151730666 @default.
- W1993001839 hasConcept C201645570 @default.
- W1993001839 hasConcept C2775908122 @default.
- W1993001839 hasConcept C2776235491 @default.
- W1993001839 hasConcept C2777416452 @default.
- W1993001839 hasConcept C2780192828 @default.
- W1993001839 hasConcept C2989005 @default.
- W1993001839 hasConcept C509974204 @default.
- W1993001839 hasConcept C71924100 @default.
- W1993001839 hasConcept C86803240 @default.
- W1993001839 hasConceptScore W1993001839C121608353 @default.
- W1993001839 hasConceptScore W1993001839C126322002 @default.
- W1993001839 hasConceptScore W1993001839C126838900 @default.
- W1993001839 hasConceptScore W1993001839C126894567 @default.
- W1993001839 hasConceptScore W1993001839C146357865 @default.
- W1993001839 hasConceptScore W1993001839C151730666 @default.
- W1993001839 hasConceptScore W1993001839C201645570 @default.
- W1993001839 hasConceptScore W1993001839C2775908122 @default.
- W1993001839 hasConceptScore W1993001839C2776235491 @default.
- W1993001839 hasConceptScore W1993001839C2777416452 @default.
- W1993001839 hasConceptScore W1993001839C2780192828 @default.
- W1993001839 hasConceptScore W1993001839C2989005 @default.
- W1993001839 hasConceptScore W1993001839C509974204 @default.
- W1993001839 hasConceptScore W1993001839C71924100 @default.
- W1993001839 hasConceptScore W1993001839C86803240 @default.
- W1993001839 hasIssue "4" @default.
- W1993001839 hasLocation W19930018391 @default.
- W1993001839 hasLocation W19930018392 @default.
- W1993001839 hasOpenAccess W1993001839 @default.
- W1993001839 hasPrimaryLocation W19930018391 @default.
- W1993001839 hasRelatedWork W1970337331 @default.
- W1993001839 hasRelatedWork W2023503398 @default.
- W1993001839 hasRelatedWork W2027294118 @default.
- W1993001839 hasRelatedWork W2065840363 @default.
- W1993001839 hasRelatedWork W2085529113 @default.
- W1993001839 hasRelatedWork W2143699516 @default.
- W1993001839 hasRelatedWork W2165532162 @default.
- W1993001839 hasRelatedWork W2534674868 @default.
- W1993001839 hasRelatedWork W2597301728 @default.
- W1993001839 hasRelatedWork W3032252569 @default.
- W1993001839 hasVolume "14" @default.
- W1993001839 isParatext "false" @default.
- W1993001839 isRetracted "false" @default.
- W1993001839 magId "1993001839" @default.
- W1993001839 workType "article" @default.